With an ongoing focus on growth disorders in children, GenSci has expanded its attention to the broader spectrum of children’s health. Integrating AI technology, GenSci covers the entire drug innovation process, from initial design and screening to process development and formulation. GenSci has formed enduring and robust partnerships with nearly 20 prominent universities, including Shanghai Jiao Tong University and Zhejiang University. Through deep cooperation and extensive coverage, it truly realizes co-creation and win-win outcomes in medical research. The groundbreaking of GenSci’s global innovation hub and R&D center enpowers the company to fully utilize its expertise in gynecology and pediatrics.

Source: The Bubble December 23, 2023 20:30 UTC